{"created":"2023-05-15T14:21:05.374953+00:00","id":4049,"links":{},"metadata":{"_buckets":{"deposit":"350ddba1-428c-4cb6-a870-82a42d899ebf"},"_deposit":{"created_by":12,"id":"4049","owners":[12],"pid":{"revision_id":0,"type":"depid","value":"4049"},"status":"published"},"_oai":{"id":"oai:iwatemed.repo.nii.ac.jp:00004049","sets":["17:78:80","89:136"]},"author_link":["12604"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2014-05","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"157","bibliographicPageStart":"152","bibliographicVolumeNumber":"37","bibliographic_titles":[{"bibliographic_title":"医薬品相互作用研究"}]}]},"item_10001_heading_23":{"attribute_name":"見出し","attribute_value_mlt":[{"subitem_heading_banner_headline":"薬学部","subitem_heading_headline":"薬物代謝動態学","subitem_heading_language":"ja"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0385-5015","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"小澤, 正吾"}],"nameIdentifiers":[{}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"エピジェネティクスに基づく医薬品相互作用　DNAメチル化阻害剤とヒストン脱アセチル化酵素阻害剤を用いた抗悪性腫瘍薬の有効性/安全性のモデュレーション","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"エピジェネティクスに基づく医薬品相互作用　DNAメチル化阻害剤とヒストン脱アセチル化酵素阻害剤を用いた抗悪性腫瘍薬の有効性/安全性のモデュレーション"}]},"item_type_id":"10001","owner":"12","path":["80","136"],"pubdate":{"attribute_name":"公開日","attribute_value":"2014-12-22"},"publish_date":"2014-12-22","publish_status":"0","recid":"4049","relation_version_is_last":true,"title":["エピジェネティクスに基づく医薬品相互作用　DNAメチル化阻害剤とヒストン脱アセチル化酵素阻害剤を用いた抗悪性腫瘍薬の有効性/安全性のモデュレーション"],"weko_creator_id":"12","weko_shared_id":12},"updated":"2023-05-15T18:03:22.480628+00:00"}